Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Amyloidose-Zentrum – Universitätsklinikum Heidelberg
Im Neuenheimer field 672Heidelberg, Germany
Email Phone Web
After a specific diagnosis has been established regarding the type of amyloidosis, the medical specialists at our Amyloidose-Zentrum will recommend an individual, interdisciplinary treatment strategy that matches the type and extent of the disorder. The strategy will be aimed at the cause of the disorder and will attempt to prevent additional amyloid being deposited. The therapy must start as early as possible, as amyloid that has already been deposited cannot be removed from the tissues.
The team includes healthcare professionals in the following areas:
Hematology and Oncology:
Stefan Schonland
Related Content
-
John C. Davis Myeloma and Amyloid Program at Tufts Medical Center’s Cancer CenterThe John C. Davis Myeloma and Amyloid Pr...
-
Centro per lo Studio delle Amiloidosi Sistemiche: Fondazione IRCCS Policlinico San Matteo di PaviaIl Centro per lo Studio e la Cura delle ...
-
Giampaolo Merlini, MDDr. Giampaolo Merlini is the Director ...
-
University of Kentucky Markey Cancer CenterThe UK Markey Cancer Center was founded ...
-
University of Utah Health, Amyloidosis ProgramAmyloidosis is a complicated disorder th...
-
Muriel FinkelMuriel Finkel is the President of Amyloi...
-
AA AmyloidosisAA amyloidosis, or secondary amyloidosis...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.